Scott M. Rocklage, Ph.D. has worked with 5AM Ventures since 2003. He initially joined as a Venture Partner, and he worked very hard to the satisfaction of the management. Soon after, in 2004, Dr. Rocklage became a managing partner in this company.
Today he boasts of more than three decades of experience in the field of healthcare management. Over the years, he has undertaken strategic leadership responsibilities which have successfully lead to the approval of various U.S New Drug Applications by FDA, and these include Omniscan™, Cubicin®, and Teslascan®.
Throughout his career, Dr. Rocklage has served in various positions in different companies. He was once the CEO and Chairman of Cubist Pharmaceuticals.
Scott Rocklage has also doubled as the Chief Executive Officer and the President of Nycomed Salutar before holding a number of R&D positions at both Catalytica and Salutar. Read more: Scott Racklage | Bloomberg and Scott Rocklage | LinkedIn
He has been part of Ilypsa, Semprus, and Miikana all of which he served as the Executive Chairman and performed exceptionally well leaving a legacy. He brought changes in these companies some of which have remained in effect to this day.
The boards of various companies have also been privileged to have Dr. Rocklage either as a member or as a chairman. He previously chaired the boards of such companies like Relypsa and Novira. Currently, he is a Board Chairman of Cidara, Rennovia, Kinestral.
Scott Rocklage is a member of the Boards of Pulmatrix (NASDAQ: PULM) and Epirus (NASDAQ: EPRS). Serving either as a member or a chairman of these boards, Dr. Rocklage has always been diligent in his duties and has been one of the most active personalities in this case.
Currently, Dr. Rocklage lives and operates from his office in Boston, MA. His rich educational background could be one of the reasons why he has been successful in his career.
Scott Rocklage attended the University of California and graduated with a B.S. in Chemistry. He is also an alumnus of MIT (the Massachusetts Institute of Technology) from where he earned a Ph.D. in Chemistry. He has since either invented or co-invented more than 30 U.S. patents. Dr. Rocklage has also peer-reviewed at least 100 publications to date.